PL1856070T3 - Nowe środki lecznicze do leczenia chorób dróg oddechowych - Google Patents

Nowe środki lecznicze do leczenia chorób dróg oddechowych

Info

Publication number
PL1856070T3
PL1856070T3 PL06708325T PL06708325T PL1856070T3 PL 1856070 T3 PL1856070 T3 PL 1856070T3 PL 06708325 T PL06708325 T PL 06708325T PL 06708325 T PL06708325 T PL 06708325T PL 1856070 T3 PL1856070 T3 PL 1856070T3
Authority
PL
Poland
Prior art keywords
respiratory diseases
treating respiratory
novel drugs
drugs
novel
Prior art date
Application number
PL06708325T
Other languages
English (en)
Inventor
Ingo Konetzki
Thierry Bouyssou
Philipp Lustenberger
Andreas Schnapp
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of PL1856070T3 publication Critical patent/PL1856070T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
PL06708325T 2005-02-24 2006-02-16 Nowe środki lecznicze do leczenia chorób dróg oddechowych PL1856070T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005008921A DE102005008921A1 (de) 2005-02-24 2005-02-24 Neue Arzneimittel zur Behandlung von Atemwegserkrankungen
EP06708325A EP1856070B1 (de) 2005-02-24 2006-02-16 Neue arzneimittel zur behandlung von atemwegserkrankungen
PCT/EP2006/060033 WO2006089859A1 (de) 2005-02-24 2006-02-16 Neue arzneimittel zur behandlung von atemwegserkrankungen

Publications (1)

Publication Number Publication Date
PL1856070T3 true PL1856070T3 (pl) 2011-12-30

Family

ID=36179764

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06708325T PL1856070T3 (pl) 2005-02-24 2006-02-16 Nowe środki lecznicze do leczenia chorób dróg oddechowych

Country Status (26)

Country Link
US (3) US20060189605A1 (pl)
EP (1) EP1856070B1 (pl)
JP (1) JP4950075B2 (pl)
KR (1) KR20070110386A (pl)
CN (1) CN101128444A (pl)
AR (1) AR055562A1 (pl)
AT (1) ATE517877T1 (pl)
AU (1) AU2006218010B2 (pl)
BR (1) BRPI0607258A2 (pl)
CA (1) CA2598914A1 (pl)
DE (1) DE102005008921A1 (pl)
DK (1) DK1856070T3 (pl)
EA (1) EA012439B1 (pl)
ES (1) ES2370653T3 (pl)
IL (1) IL185444A0 (pl)
MX (1) MX2007010363A (pl)
MY (1) MY146802A (pl)
NO (1) NO20073176L (pl)
NZ (1) NZ561743A (pl)
PE (1) PE20061097A1 (pl)
PL (1) PL1856070T3 (pl)
TW (1) TWI369988B (pl)
UA (1) UA90504C2 (pl)
UY (1) UY29394A1 (pl)
WO (1) WO2006089859A1 (pl)
ZA (1) ZA200704727B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005008921A1 (de) * 2005-02-24 2006-08-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von Atemwegserkrankungen
US7423146B2 (en) 2005-11-09 2008-09-09 Boehringer Ingelheim International Gmbh Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
PE20081358A1 (es) * 2006-08-22 2008-10-31 Boehringer Ingelheim Int Combinaciones farmacologicas para el tratamiento de enfermedades de la vias aereas
EP2056836A1 (en) * 2006-08-22 2009-05-13 Boehringer Ingelheim International GmbH Powder formulations for inhalation containing enantiomerically pure beta-agonists
PE20080425A1 (es) * 2006-08-22 2008-06-16 Boehringer Ingelheim Int Formulacion aerosol para la inhalacion de beta-agonistas
UY30550A1 (es) * 2006-08-22 2008-03-31 Boehringer Ingelheim Int Nuevos beta-agonistas enantioméricamente puros, procedimientos para su preparacion y su uso como medicamentos
EP2093219A1 (de) 2008-02-22 2009-08-26 Boehringer Ingelheim International Gmbh Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel
GB201217330D0 (en) * 2012-09-28 2012-11-14 Univ Cardiff Therapeutic for treating inflammatory lung disorders
ES2737227T3 (es) 2014-12-24 2020-01-10 Kither Biotech S R L Péptido inhibidor de gamma PI3K novedoso para el tratamiento de enfermedades del sistema respiratorio

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3026534A1 (de) 1980-07-12 1982-03-18 C.H. Boehringer Sohn, 6507 Ingelheim 3,1-benzoxazin-2-one, ihre herstellung und verwendung
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
US4570630A (en) * 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
DE3609152A1 (de) * 1986-03-19 1987-09-24 Bayer Ag Verfahren zur herstellung des (-)-antipoden des (e)-1-cyclohexyl-4,4-dimethyl- 3-hydroxy-2-(1,2,4-triazol-1-yl)-pent-1-ens
BRPI0409198A (pt) * 2003-04-04 2006-05-02 Novartis Ag derivados quinolin-2-ona para o tratamento de doenças de vias aéreas
DE102004003428A1 (de) * 2004-01-23 2005-08-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Beta-2-Agonisten, und deren Verwendung als Arzneimittel
US7220742B2 (en) * 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE102005008921A1 (de) * 2005-02-24 2006-08-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von Atemwegserkrankungen
US7423146B2 (en) * 2005-11-09 2008-09-09 Boehringer Ingelheim International Gmbh Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
PE20081358A1 (es) * 2006-08-22 2008-10-31 Boehringer Ingelheim Int Combinaciones farmacologicas para el tratamiento de enfermedades de la vias aereas
PE20080425A1 (es) * 2006-08-22 2008-06-16 Boehringer Ingelheim Int Formulacion aerosol para la inhalacion de beta-agonistas

Also Published As

Publication number Publication date
ZA200704727B (en) 2008-09-25
UY29394A1 (es) 2006-10-02
WO2006089859A1 (de) 2006-08-31
KR20070110386A (ko) 2007-11-16
AR055562A1 (es) 2007-08-22
DE102005008921A1 (de) 2006-08-31
US20090105236A1 (en) 2009-04-23
EA012439B1 (ru) 2009-10-30
EA200701615A1 (ru) 2008-02-28
US20110053926A1 (en) 2011-03-03
ES2370653T3 (es) 2011-12-21
NO20073176L (no) 2007-09-17
CA2598914A1 (en) 2006-08-31
AU2006218010B2 (en) 2013-02-14
ATE517877T1 (de) 2011-08-15
UA90504C2 (ru) 2010-05-11
MY146802A (en) 2012-09-28
JP2008531518A (ja) 2008-08-14
MX2007010363A (es) 2007-09-25
PE20061097A1 (es) 2006-11-14
EP1856070B1 (de) 2011-07-27
TW200640465A (en) 2006-12-01
DK1856070T3 (da) 2011-09-26
US20060189605A1 (en) 2006-08-24
CN101128444A (zh) 2008-02-20
AU2006218010A1 (en) 2006-08-31
NZ561743A (en) 2009-09-25
TWI369988B (en) 2012-08-11
JP4950075B2 (ja) 2012-06-13
IL185444A0 (en) 2008-01-06
EP1856070A1 (de) 2007-11-21
BRPI0607258A2 (pt) 2009-08-25

Similar Documents

Publication Publication Date Title
IL226562A0 (en) Pharmacy combinations containing benzoxazine for the treatment of respiratory diseases
IL190338A0 (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
IL194076A0 (en) Imidazolothiazole compounds for the treatment of disease
PT3424932T (pt) Boronoftalidas para utilização terapêutica
IL197316A0 (en) Buprenophine-wafer for drug substitution therapy
ZA200701584B (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
IL180931A0 (en) Medicaments for treating chronic respiratory disease
IL187085A0 (en) Combination therapy comprising diaryl ureas for treating diseases
IL190652A0 (en) Novel pharmaceutical combinations for the treatment of respiratory disorders
IL185444A0 (en) Novel drugs for treating respiratory diseases
ZA200606547B (en) Benzoxazine for treating respiratory tract diseases
GB0410399D0 (en) The treatment of respiratory disease
GB0410398D0 (en) The treatment of respiratory disease
IL197125A0 (en) Drug combinations for treating airway diseases
GB0701456D0 (en) Treatment for respiratory disease
EP1871344A4 (en) INHIBITABLE MEDICINAL PRODUCT
EP2059238A4 (en) THERAPEUTIC COMPOUNDS FOR DISEASES AND DISORDERS
EP1927353A4 (en) MEANS FOR THE TREATMENT OF CORNEAL DISEASES
ZA200606780B (en) Compounds for the treatment of diseases
GB0520152D0 (en) Treatment of respiratory disease
ZA200802948B (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
GB0524945D0 (en) Medicament inhaler
GB2430622B (en) Inhaled combination therapy
GB0512757D0 (en) Treatment of respiratory disorders
IL177531A0 (en) Compounds for the treatment of diseases